(Q41604480)

4 October 2017

1 reference

title

Diabetic vascular complications (English)

1 reference

4 October 2017

Cooper ME

1

1 reference

4 October 2017

Gilbert RE

series ordinal

2

1 reference

4 October 2017

Jerums G

series ordinal

3

1 reference

4 October 2017

publication date

1 September 1997

1 reference

Clinical and Experimental Pharmacology and Physiology

4 October 2017

published in

1 reference

4 October 2017

volume

24

1 reference

4 October 2017

issue

9-10

1 reference

4 October 2017

page(s)

770-775

1 reference

Prevention and treatment of the complications of diabetes mellitus

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB02130.X

Glomerular hyperfiltration in human diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB02130.X

Lilly Lecture 1993. Glycation and diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB02130.X

Aging of proteins: isolation and identification of a fluorescent chromophore from the reaction of polypeptides with glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB02130.X

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB02130.X

An agent cleaving glucose-derived protein crosslinks in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB02130.X

Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB02130.X

Complications: neuropathy, pathogenetic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB02130.X

Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB02130.X

Large conduit arteries in hypertension: role of the vascular renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB02130.X

Vasoactive hormones and renal sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB02130.X

Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB02130.X

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB02130.X

Angiotensin receptor antagonists: focus on losartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB02130.X

Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB02130.X

Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB02130.X

Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB02130.X

10.1111/J.1440-1681.1997.TB02130.X

21 January 2018

Identifiers

DOI

1 reference

4 October 2017

1 reference